Literature DB >> 28567670

Severity of Hypertension Correlates with Risk of Thromboembolic Stroke.

Hui Pang1, Bing Han2, Qiang Fu2, Qiumei Cao2.   

Abstract

Hypertension plays a significant role in the development of atrial fibrillation (AF) and its complications. The coexistence of the two diseases increases the risk of thromboembolism events. Although CHADS2 and CHA2DS2-VASc scores have been used in the evaluation of the thromboembolism events in AF patients, the different levels of the blood pressure are not appropriately recognized. In this study, the 970 AF patients were divided into three groups according to the severity of hypertension. The CHADS2 and CHA2DS2-VASc scores in the patients of grade 3 hypertension were significantly higher than those of the patients with grade 1 and 2 hypertension, respectively (P < 0.05). Both the CHADS2 and CHA2DS2-VASc scores were positively related to the severity of hypertension (P < 0.001). Our data demonstrated that three grades for hypertensive subjects with AF significantly improved antithrombotic risk stratification in addition to current clinical risk stratification models, such as CHADS2 and CHA2DS2-VASc scores.

Entities:  

Keywords:  Atrial fibrillation; CHA2DS2-VASc score; CHADS2 score; Hypertension

Mesh:

Year:  2017        PMID: 28567670     DOI: 10.1007/s12265-017-9754-0

Source DB:  PubMed          Journal:  J Cardiovasc Transl Res        ISSN: 1937-5387            Impact factor:   4.132


  16 in total

Review 1.  Atrial Fibrillation and Hypertension: Mechanistic, Epidemiologic, and Treatment Parallels.

Authors:  Adedotun A Ogunsua; Amir Y Shaikh; Mohamed Ahmed; David D McManus
Journal:  Methodist Debakey Cardiovasc J       Date:  2015 Oct-Dec

Review 2.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy
Journal:  J Am Coll Cardiol       Date:  2014-03-28       Impact factor: 24.094

Review 3.  Role of the autonomic nervous system in atrial fibrillation: pathophysiology and therapy.

Authors:  Peng-Sheng Chen; Lan S Chen; Michael C Fishbein; Shien-Fong Lin; Stanley Nattel
Journal:  Circ Res       Date:  2014-04-25       Impact factor: 17.367

4.  Comparison of cardiovascular risk factors and survival in patients with ischemic or hemorrhagic stroke.

Authors:  Karin M Henriksson; Bahman Farahmand; Signild Åsberg; Nils Edvardsson; Andreas Terént
Journal:  Int J Stroke       Date:  2011-12-08       Impact factor: 5.266

5.  Effect of atrial fibrillation on atrial thrombogenesis in humans: impact of rate and rhythm.

Authors:  Han S Lim; Scott R Willoughby; Carlee Schultz; Cheryl Gan; Muayad Alasady; Dennis H Lau; Darryl P Leong; Anthony G Brooks; Glenn D Young; Peter M Kistler; Jonathan M Kalman; Matthew I Worthley; Prashanthan Sanders
Journal:  J Am Coll Cardiol       Date:  2013-01-16       Impact factor: 24.094

Review 6.  Prediction of atrial fibrillation development and progression: Current perspectives.

Authors:  Konstantinos Vlachos; Konstantinos P Letsas; Panagiotis Korantzopoulos; Tong Liu; Stamatis Georgopoulos; Athanasios Bakalakos; Nikolaos Karamichalakis; Sotirios Xydonas; Michael Efremidis; Antonios Sideris
Journal:  World J Cardiol       Date:  2016-03-26

7.  Tachycardia-induced silencing of subcellular Ca2+ signaling in atrial myocytes.

Authors:  Maura Greiser; Benoît-Gilles Kerfant; George S B Williams; Niels Voigt; Erik Harks; Katharine M Dibb; Anne Giese; Janos Meszaros; Sander Verheule; Ursula Ravens; Maurits A Allessie; James S Gammie; Jolanda van der Velden; W Jonathan Lederer; Dobromir Dobrev; Ulrich Schotten
Journal:  J Clin Invest       Date:  2014-10-20       Impact factor: 14.808

8.  Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation.

Authors:  A John Camm; Gabriele Accetta; Giuseppe Ambrosio; Dan Atar; Jean-Pierre Bassand; Eivind Berge; Frank Cools; David A Fitzmaurice; Samuel Z Goldhaber; Shinya Goto; Sylvia Haas; Gloria Kayani; Yukihiro Koretsune; Lorenzo G Mantovani; Frank Misselwitz; Seil Oh; Alexander G G Turpie; Freek W A Verheugt; Ajay K Kakkar
Journal:  Heart       Date:  2016-09-19       Impact factor: 5.994

9.  2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Authors:  Giuseppe Mancia; Robert Fagard; Krzysztof Narkiewicz; Josep Redon; Alberto Zanchetti; Michael Böhm; Thierry Christiaens; Renata Cifkova; Guy De Backer; Anna Dominiczak; Maurizio Galderisi; Diederick E Grobbee; Tiny Jaarsma; Paulus Kirchhof; Sverre E Kjeldsen; Stéphane Laurent; Athanasios J Manolis; Peter M Nilsson; Luis Miguel Ruilope; Roland E Schmieder; Per Anton Sirnes; Peter Sleight; Margus Viigimaa; Bernard Waeber; Faiez Zannad; Josep Redon; Anna Dominiczak; Krzysztof Narkiewicz; Peter M Nilsson; Michel Burnier; Margus Viigimaa; Ettore Ambrosioni; Mark Caufield; Antonio Coca; Michael Hecht Olsen; Roland E Schmieder; Costas Tsioufis; Philippe van de Borne; Jose Luis Zamorano; Stephan Achenbach; Helmut Baumgartner; Jeroen J Bax; Héctor Bueno; Veronica Dean; Christi Deaton; Cetin Erol; Robert Fagard; Roberto Ferrari; David Hasdai; Arno W Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Patrizio Lancellotti; Ales Linhart; Petros Nihoyannopoulos; Massimo F Piepoli; Piotr Ponikowski; Per Anton Sirnes; Juan Luis Tamargo; Michal Tendera; Adam Torbicki; William Wijns; Stephan Windecker; Denis L Clement; Antonio Coca; Thierry C Gillebert; Michal Tendera; Enrico Agabiti Rosei; Ettore Ambrosioni; Stefan D Anker; Johann Bauersachs; Jana Brguljan Hitij; Mark Caulfield; Marc De Buyzere; Sabina De Geest; Geneviève Anne Derumeaux; Serap Erdine; Csaba Farsang; Christian Funck-Brentano; Vjekoslav Gerc; Giuseppe Germano; Stephan Gielen; Herman Haller; Arno W Hoes; Jens Jordan; Thomas Kahan; Michel Komajda; Dragan Lovic; Heiko Mahrholdt; Michael Hecht Olsen; Jan Ostergren; Gianfranco Parati; Joep Perk; Jorge Polonia; Bogdan A Popescu; Zeljko Reiner; Lars Rydén; Yuriy Sirenko; Alice Stanton; Harry Struijker-Boudier; Costas Tsioufis; Philippe van de Borne; Charalambos Vlachopoulos; Massimo Volpe; David A Wood
Journal:  Eur Heart J       Date:  2013-06-14       Impact factor: 29.983

10.  All-cause mortality in 272,186 patients hospitalized with incident atrial fibrillation 1995-2008: a Swedish nationwide long-term case-control study.

Authors:  Tommy Andersson; Anders Magnuson; Ing-Liss Bryngelsson; Ole Frøbert; Karin M Henriksson; Nils Edvardsson; Dritan Poçi
Journal:  Eur Heart J       Date:  2013-01-14       Impact factor: 29.983

View more
  1 in total

1.  Risk of left atrial appendage thrombus in patients with atrial fibrillation and chronic kidney disease.

Authors:  Monika Budnik; Monika Gawałko; Iwona Gorczyca; Beata Uziębło-Życzkowska; Paweł Krzesiński; Janusz Kochanowski; Piotr Scisło; Anna Michalska; Olga Jelonek; Katarzyna Starzyk; Agnieszka Jurek; Marek Kiliszek; Beata Wożakowska-Kapłon; Grzegorz Gielerak; Krzysztof J Filipiak; Grzegorz Opolski; Agnieszka Kapłon-Cieślicka
Journal:  Cardiol J       Date:  2020-03-24       Impact factor: 2.737

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.